Gene: BTBD3
Official Full Name: BTB domain containing 3provided by HGNC
Gene Summary: Enables identical protein binding activity. Predicted to be involved in cerebral cortex development and dendrite morphogenesis. Predicted to be located in nucleus. Predicted to be active in cytosol. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO30146 | BTBD3 Knockout cell line (HeLa) | Human | BTBD3 | 1:3~1:6 | Negative | Online Inquiry |
KO30147 | BTBD3 Knockout cell line (HCT 116) | Human | BTBD3 | 1:2~1:4 | Negative | Online Inquiry |
KO30148 | BTBD3 Knockout cell line (HEK293) | Human | BTBD3 | 1:3~1:6 | Negative | Online Inquiry |
KO30149 | BTBD3 Knockout cell line (A549) | Human | BTBD3 | 1:3~1:4 | Negative | Online Inquiry |
BTBD3 Gene Knockout Cell Lines are specialized cell lines in which the BTBD3 gene has been genetically disrupted, allowing for the study of the gene's functions and the biological pathways it influences. These knockout cell lines serve as a critical tool for researchers aiming to investigate the role of BTBD3 in cellular processes such as protein degradation, cellular signaling, and disease development. The knockout is achieved through state-of-the-art CRISPR/Cas9 technology, ensuring high specificity and efficiency in disrupting the target gene, enabling scientists to elucidate its biological significance.
The primary function of the BTBD3 knockout cell lines is to create an environment where the absence of BTBD3 allows for the dissection of its role within various cellular contexts. By analyzing these cells, researchers can gain insights into the pathways mediated by BTBD3, which has been implicated in several diseases, including cancer and neurodegenerative disorders. Moreover, understanding its function can illuminate potential therapeutic targets, enhancing both basic and applied biomedical research efforts.
The scientific importance of these cell lines lies in their versatility; they can be utilized in various applications, including drug discovery, mechanistic studies, and biomarker identification. Compared to traditional gene silencing methods such as siRNA or shRNA, gene knockout models provide more robust and stable gene disruption, permitting prolonged studies with more reliable phenotypic outcomes.
For researchers and clinicians alike, BTBD3 Gene Knockout Cell Lines offer a unique value proposition. Their ability to facilitate in-depth mechanistic investigations allows users to generate credible data that can lead to novel therapeutic strategies, contributing significantly to the advancement of personalized medicine approaches.
With expertise in genetic engineering and cellular biology, our company is dedicated to providing high-quality biological products that empower researchers to achieve their scientific goals. Our commitment to innovation ensures that we offer cutting-edge solutions that meet the evolving needs of the scientific community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.